肺部切除术是包括肺癌在内多种胸腔疾病的重要治疗方法，但术后罕见而严重的并发症如乳糜漏（发生率0.25%-3%）常导致住院时间延长、胸腔引流时间延长及康复延迟。
适应症：Thoracic Neoplasms
入组条件
纳入标准
- Age between 18 - 80 years
- Body mass index \<35 kg/m2
- Suitable for minimally invasive surgery
- Willingness to participate as demonstrated by giving informed consent
- Project-specific Criteria:
- \. Patients performed lobectomy with lymph node dissection
排除标准
- Contraindication to general anesthesia
- Severe concomitant illness that drastically shortens life expectancy or increases the risk of therapeutic intervention
- Untreated active infection
- Non-correctable coagulopathy
- Emergency surgery
- Vulnerable population (e.g. mentally disabled, pregnancy)
- Project-specific Criteria
- Segmentectomy
- Pleurodesis
- Esophageal procedures
- Redo/readmitted patients for lung resection
- Chylothorax (Triglyceride \> 110 mL, excluded at day 1 routine lab check)
- Air leak (\> 30 mL/min when back to ward)
- Heart Failure
- Renal failure (estimated GFR \< 30; CKD grading stage 4-5)
- Moderate to severe adhesion (defined at randomization by surgeon; criteria include estimated surface area of adhesion and staging)
- History of tuberculosis or empyema
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。